methylprednisolone and osteoprotegerin

methylprednisolone has been researched along with osteoprotegerin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamopoulos, IE; Athanasou, NA; Edwards, JR; Ferguson, DJ; Wordsworth, PB1
Malek, HA; Samir, SM1
Huang, YX; Tao, JG; Zhao, HX1
Deng, J; Dong, WT; Li, Q; Peng, WX; Wang, CQ; Wei, ZA; Wu, JH; Yang, LL; Ye, C; Zhang, J1
Bauer, N; Böcker, W; Daghma, DES; El Khassawna, T; Hassan, F; Heiss, C; Hose, D; Ignatius, A; Kern, S; Langenstein, J; Lips, KS; Malhan, D; Merboth, F; Rösen-Wolff, A; Rosenbaum, D; Rupp, M; Schlagenhauf, A; Schulze, F; Secklinger, A; Stoetzel, S; Wilke, HJ1

Other Studies

5 other study(ies) available for methylprednisolone and osteoprotegerin

ArticleYear
Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
    Human pathology, 2006, Volume: 37, Issue:9

    Topics: Adult; Anti-Inflammatory Agents; Arthritis; Bone Resorption; Carrier Proteins; Cell Differentiation; Cells, Cultured; Cytokines; Diphosphonates; Glycoproteins; Histiocytosis, Non-Langerhans-Cell; Humans; Immunohistochemistry; Leukocytes, Mononuclear; Macrophages; Male; Membrane Glycoproteins; Methylprednisolone; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Osteoclasts; Osteoprotegerin; Pamidronate; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Skin Diseases; Synovial Fluid; Tumor Necrosis Factor-alpha

2006
Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2014, Volume: 65, Issue:5

    Topics: Age Factors; Aging; Alkaline Phosphatase; Animals; Bone Density; Bone Remodeling; Calcium; Cannabinoid Receptor Antagonists; Gene Expression Regulation; Glucocorticoids; Male; Methylprednisolone; Osteocalcin; Osteoporosis; Osteoprotegerin; Piperidines; Pyrazoles; RANK Ligand; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Messenger; Tibia

2014
ST1926 Attenuates Steroid-Induced Osteoporosis in Rats by Inhibiting Inflammation Response.
    Journal of cellular biochemistry, 2017, Volume: 118, Issue:8

    Topics: Adamantane; Alkaline Phosphatase; Animals; beta Catenin; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Resorption; Cinnamates; Gene Expression Regulation; Male; Methylprednisolone; Methylprednisolone Acetate; NF-kappa B; Osteoblasts; Osteoclasts; Osteonecrosis; Osteoprotegerin; Rats; Rats, Wistar; Signal Transduction; Wnt3A Protein

2017
MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway.
    Experimental biology and medicine (Maywood, N.J.), 2017, Volume: 242, Issue:12

    Topics: Animals; Femur Head Necrosis; Gene Expression Regulation; Glucocorticoids; Homeodomain Proteins; Male; Methylprednisolone; MicroRNAs; Osteoprotegerin; RANK Ligand; Rats; Rats, Sprague-Dawley; Receptor Activator of Nuclear Factor-kappa B; Repressor Proteins; Signal Transduction

2017
Osteocyte Regulation of Receptor Activator of NF-κB Ligand/Osteoprotegerin in a Sheep Model of Osteoporosis.
    The American journal of pathology, 2017, Volume: 187, Issue:8

    Topics: Animals; Bone Density; Disease Models, Animal; Female; Methylprednisolone; NF-kappa B; Osteocytes; Osteoporosis; Osteoprotegerin; Ovariectomy; RANK Ligand; Sheep; Signal Transduction; Spine

2017